Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TBX-3400
i
Other names:
TBX-3400
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Taiga Biotech
Drug class:
Cytotoxic T lymphocyte stimulant
Related drugs:
‹
tretinoin (6)
CAN-3110 (1)
DOC1021 (1)
INO-5401 (1)
GL-ONC1 (1)
cytotoxic lymphocyte-based cancer vaccine (0)
CRX100 (0)
EO2401 (0)
EO2463 (0)
ET140203 (0)
GRANITE (0)
GSK2130579A (0)
GSK2302025A (0)
GX301 (0)
HA-1 T TCR T Cell Immunotherapy (0)
HSV G207 (0)
IMA-901 (0)
IMA910 (0)
MT-201 (0)
NC410 (0)
OCV C01 (0)
PGV-001 (0)
PV-001-DC (0)
RTX-321 (0)
SQZ-PBMC-HPV (0)
tabelecleucel (0)
SB-313 (0)
AGI-134 (0)
S-588410 (0)
TBI-1401 (0)
mouse TYRP2 DNA (0)
tretinoin (6)
CAN-3110 (1)
DOC1021 (1)
INO-5401 (1)
GL-ONC1 (1)
cytotoxic lymphocyte-based cancer vaccine (0)
CRX100 (0)
EO2401 (0)
EO2463 (0)
ET140203 (0)
GRANITE (0)
GSK2130579A (0)
GSK2302025A (0)
GX301 (0)
HA-1 T TCR T Cell Immunotherapy (0)
HSV G207 (0)
IMA-901 (0)
IMA910 (0)
MT-201 (0)
NC410 (0)
OCV C01 (0)
PGV-001 (0)
PV-001-DC (0)
RTX-321 (0)
SQZ-PBMC-HPV (0)
tabelecleucel (0)
SB-313 (0)
AGI-134 (0)
S-588410 (0)
TBI-1401 (0)
mouse TYRP2 DNA (0)
›
Associations
News
Trials
Filter by
Latest
almost3years
Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies (clinicaltrials.gov)
P1/2, N=60, Recruiting, Taiga Biotechnologies, Inc. | Phase classification: P1 --> P1/2 | N=20 --> 60 | Trial completion date: Apr 2022 --> Apr 2023 | Trial primary completion date: Jan 2022 --> Jan 2023
almost 3 years ago
Phase classification • Enrollment change • Trial completion date • Trial primary completion date
|
CD69 (CD69 Molecule)
|
TBX-3400
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login